PLAY PODCASTS
NDM-Producing Enterobacterales: Applying Best Practices in Complex Clinical Scenarios
Episode 336

NDM-Producing Enterobacterales: Applying Best Practices in Complex Clinical Scenarios

Listen to expert faculty discuss management of CRE infections, particularly NDM-producing Enterobacterales, including IDSA guidance recommendations and the latest data on current and future therapies.

Decera Clinical Education Infectious Disease Podcast · Emily Heil PharmD MS BCIDP AAHIVP, Laila Woc-Colburn MD, Trevor Van Schooneveld MD FSHEA FACP

November 16, 202317m 1s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode,Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections caused by NDM-producing Enterobacterales, including: 

  • Ambler classification of β-lactamases
  • Mechanisms of resistance
  • 2023 IDSA guidance recommendations
  • The latest clinical data by antimicrobial regimen:
  • Ceftazidime/avibactam and aztreonam
  • Cefiderocol
  • Investigational aztreonam/avibactam
  • Clinical case of NDM-producing E. coli with pan-β-lactam resistance

Program Director:

Trevor Van Schooneveld, MD, FSHEA, FACP 
Professor, Division of Infectious Diseases
Program Director, Infectious Diseases Fellowship
Medical Director, Antimicrobial Stewardship Program
University of Nebraska Medical Center
Omaha, Nebraska

Faculty:

Emily Heil, PharmD, MS, BCIDP, AAHIVP
Associate Professor
Department of Pharmacy
University of Maryland 
School of Pharmacy
ID Clinical Pharmacy Specialist
University of Maryland Medical Center
Baltimore, Maryland

Laila Woc-Colburn, MD
Associate Professor
Division of Infectious Diseases
Emory University School of Medicine 
Atlanta, Georgia

Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Follow along with a downloadable slideset at: 
https://bit.ly/476v2wI

Link to full program:
https://bit.ly/40HyvPy


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

porin mutationsassemblesimultaneousapeks-npcefepime/taniborbactamcreceftazidime/avibactammetallo-beta-lactamaserevisitlaila woc-colburnmeropenem/xeruborbactamantimicrobial resistancecredible-craztreonamcarbapenemasendmcefepime/zidebactammechanisms of resistanceoxarisk factorsefflux pumpspan-resistanceaztreonam/avibactamcefiderocolpk/pdimpvimtigecyclineeravacyclinemblkpc